51勛圖厙

Tag - stem-cells

 
Menu
Search
 
July 24, 2026
 

Home Delivery
Subscribe for more access

STEM CELLS

A cardiac muscle cell sheet that uses induced pluripotent stem cells
51勛圖厙 / Science & Health
Jul 22, 2026
Another iPS product approved for public insurance coverage in Japan
It is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.
Long-term safety has been confirmed after neural progenitor cells derived from iPS cells were transplanted into patients with spinal cord injuries, a team of researchers at Keio University has said.
51勛圖厙 / Science & Health
Jul 21, 2026
Long-term safety of iPS spinal cord therapy confirmed in Japan
The team plans to launch an investigator-initiated clinical trial as early as next year to bring it into practical use.
A Japanese startup tested a catheter injection of iPS heart muscle cells on a patient at Shinshu University Hospital in late March.
51勛圖厙 / Science & Health
Jun 13, 2026
Japan startup tests catheter injection of iPS heart muscle cells
The Tokyo-based company hopes to develop a minimally invasive treatment method that does not require surgery.
IPS cells cultured by Sumitomo Pharma
51勛圖厙 / Science & Health
May 13, 2026
Health panel approves coverage for iPS cell-derived Parkinson＊s disease treatment
The approval of Sumitomo Pharma＊s Amchepry makes it the world＊s first commercialized medical product derived from iPS cells.
A Japanese research team has developed miniaturized testicular tissues called testicular organoids from mouse embryonic stem cells, in a world first.
51勛圖厙 / Science & Health
Feb 27, 2026
Japanese researchers create mouse testicular organoids in vitro
Two of the researchers were also the first to create ovarian organoids from mouse embryonic stem cells, in 2021.
An iPS cell-derived heart muscle sheet developed by Cuorips
51勛圖厙 / Science & Health / FOCUS
Feb 20, 2026
iPS cell-based products win conditional approval from health ministry panel
The endorsement was based on small-scale clinical studies that confirmed only their safety and ※presumed§ their efficacy.
Myocardial sheets made from iPS cells
51勛圖厙
Feb 19, 2026
Japan panel OKs medical products using iPS cells
The products, if approved by the health minister, are expected to be the world＊s first of their kind.
A clinical trial by a Tokyo-based venture company has confirmed that transplanting cardiac muscle cell clusters created from iPS cells into patients with severe heart failure improved their cardiac functions and symptoms.
51勛圖厙 / Science & Health
Dec 13, 2025
Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants
According to Friday＊s announcement, the transplant was performed on 10 patients, and no major safety issues were confirmed.
With concerns rising over babies whose genetic makeup has been altered to accommodate the parents' preferences, the government aims to submit related legislation during next year's ordinary parliamentary session at the earliest.
51勛圖厙
Dec 4, 2025
Japan eyes ban on gene-edited babies
The government aims to submit related legislation during next year＊s ordinary parliamentary session at the earliest.
A Japanese research team comprising researchers from Kyoto University's Center for iPS Cell Research and Application and other institutions succeeded in producing iPS cells by adding artificially synthesized ribonucleic acid to human blood cells.
51勛圖厙 / Science & Health
Dec 4, 2025
Japan team develops effective method to create iPS cells from blood
While a method to create iPS cells using skin cells and synthetic RNA has already been developed, it had been thought to be difficult to produce iPS cells from blood cells.
A research team from Kyoto University has announced that it is the first in the world to create 3D jawbone-like organoids from human induced pluripotent stem, or iPS, cells.
51勛圖厙 / Science & Health
Aug 19, 2025
Kyoto University group successfully creates jawbone from iPS cells
The team expects that its method will be applied to regenerative medicine and drug discovery.
Sumitomo Pharma applied to Japanese regulators for manufacturing and marketing authorization aimed at treating patients with advanced Parkinson's disease.
51勛圖厙 / Science & Health
Aug 5, 2025
Drugmaker in Japan seeks approval for stem cell treatment for Parkinson＊s
A trial led by Kyoto University researchers indicated treatment using induced Pluripotent Stem cells was safe and successful in improving symptoms of the disease.
A regenerative medicine startup, Kyoto-based iHeart Japan, said Monday that it has conducted a clinical trial to transplant a treatment sheet containing cardiac muscle cells derived from human induced pluripotent stem cells into a patient with a heart muscle disease.
51勛圖厙 / Science & Health
Jul 29, 2025
Japan startup transplants iPS cells for heart treatment in clinical trial
The layered sheet containing three types of cells and gelatin particles were placed on the surface of the heart, and are expected to improve the heart＊s contractions.
A screenshot of a health ministry website shows an application form to submit documents for approval of a regenerative medicine program.
51勛圖厙 / Science & Health
Jul 28, 2025
Health bureaus＊ inconsistencies on regenerative medicine plans spark outcry
In one case, a regional health and welfare bureau immediately approved a regenerative medicine program but a different bureau rejected the same treatment plan.
By pioneering stem cell therapies, Japan is not only treating disease but also seeking to rejuvenate a nation grappling with aging and decline.
COMMENTARY / Japan
Jun 20, 2025
Japan is helping lead the way in regenerative medicine
In pristine labs across Japan, scientists are tinkering with the architecture of regeneration.
A Japanese team has started a final-stage clinical trial to administer to patients with familial Alzheimer's disease a drug discovered using iPS cells.
51勛圖厙 / Science & Health
Jun 4, 2025
Japanese team starts final-stage trial for iPS drug to treat Alzheimer＊s
Through the trial, which began in May, the team aims to confirm the safety and efficacy of the treatment, with hopes of obtaining regulatory approval.
Kyoto University's Center for iPS Cell Research and Application in Kyoto
51勛圖厙 / Science & Health
Apr 23, 2025
Japan team treats chronic kidney disease with iPS cells in mice
The hope is such an achievement leads to the development of an effective therapy for chronic kidney disease.
A 3D rendering of multiple induced pluripotent stem cells
51勛圖厙
Apr 18, 2025
University of Osaka team develops miniature livers from iPS cells
The team expects the small livers can be used to treat patients with end-stage liver disease.
Parkinson's disease is a neurodegenerative condition in which motor function is impaired due to a decrease in nerve cells that produce dopamine, a chemical that works in the brain.
51勛圖厙 / Science & Health
Apr 17, 2025
Japan succeeds in improving Parkinson＊s symptoms with iPS cells
A trial saw nerve cells made from iPS cells transplanted into patients＊ brains.
It is the first transplant surgery in the hospital's clinical trial for treating Type 1 diabetes through the transplantation of pancreatic cell sheets made from iPS cells.
51勛圖厙
Apr 15, 2025
Kyoto hospital succeeds in iPS sheet transplant to diabetic patient
It is the first clinical application of such sheets in Japan.
Japan scientists identify clusters of protein believed to trigger Alzheimer＊s disease
A team of researchers said they found a ※seed§ that accelerates the amyloid beta accumulation process in the brain, naming it ※Peak 1 amyloid beta,§ as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" 〞 an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi＊s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan＊s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo＊s Shinjuku Ward.
Kabukicho: Tokyo＊s ＆stadium of desire＊

Longform

For many people, utility poles and power lines have become such a familiar part of Japan＊s landscape that they often go unnoticed.
Why Japan＊s utility poles won＊t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51勛圖厙

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER